

Formulation Development
Small-molecule synthesis with absolute stability.
Operating from Bangalore's biotech corridor, we develop high-efficacy small-molecule therapies for chronic metabolic diseases, accelerating the transition from research to market-ready products.
Clinical Metrics
Engineered for global licensing.
100%
Dossier Readiness
Active
ROC Bangalore Status
Metabolic
Therapeutic Focus




Core Focus
Synthesis to market-ready formulations.
Therapeutic Pipeline
Metabolic & Cardiovascular
We specialize in high-efficacy formulation development targeting chronic metabolic disorders, optimizing bioavailability and molecular stability under rigorous stress testing.
Regulatory Compliance
Transparent Dossier Tracking
Every licensed formulation is supported by complete, audit-ready regulatory dossiers, accelerating approvals for our international distribution partners.
Initiate formulation licensing.
Partner with Neolix Pharma for compliant, high-stability small-molecule formulations. Our Bangalore-based clinical team is ready to deliver complete regulatory dossiers.
